Table of Contents
ToggleAcute lymphoblastic leukaemia (ALL) is a type of cancer that affects white blood cells and can develop rapidly. While ALL is more common in children, it also affects teenagers and young adults. Another main type of leukaemia that can occur in this age group is acute myeloid leukaemia (AML).
If you are looking for information about ALL in people of all ages, please refer to our general ALL section.
Leukaemia is a cancer of the white blood cells. Normally, white blood cells develop, mature, and reproduce in an orderly manner in the bone marrow—the soft tissue inside bones where blood cells are produced. In leukaemia, the process becomes uncontrolled, leading to the continuous production of immature white blood cells called blasts. These immature cells accumulate in the bone marrow, crowding out healthy cells and reducing the body’s ability to:
Many of the symptoms of ALL result from a reduction in healthy blood cells. Symptoms can vary but may include:
It is important to remember that these symptoms can be caused by conditions other than ALL. However, if you are concerned, it is important to speak to your GP. They will conduct an examination and, if necessary, refer you to a specialist for further tests.
The exact cause of ALL is unknown, but ongoing research aims to identify potential factors. Certain genetic conditions can increase the risk of developing ALL. These include:
These are genetic conditions present from birth. However, most cases of ALL do not have a known specific cause.
If you think you may have symptoms of ALL, speak to your GP. They can discuss your concerns, perform an examination, and arrange any necessary tests.
Understanding leukaemia involves knowing how blood and bone marrow function. Leukaemia is a cancer that affects the white blood cells produced in the bone marrow.
Bone marrow is a spongy tissue found inside bones that acts as a blood cell factory. It produces millions of blood cells daily through a process that starts with stem cells. Stem cells can develop into different types of blood cells, depending on the body’s needs.
White Blood Cells (WBCs):
These cells are vital for fighting infections and keeping the immune system strong.
Red Blood Cells (RBCs):
RBCs transport oxygen from the lungs throughout the body, supplying energy and promoting proper organ function.
Platelets:
Platelets help clot blood, preventing excessive bleeding from cuts and injuries.
The bone marrow produces new blood cells, initially in an immature state known as blasts. The main role of blast cells is to multiply and create more blood cells. However, blast cells cannot carry oxygen, fight infection, or clot blood until they mature.
Once the blood cells are fully developed, they leave the bone marrow and enter the bloodstream to perform their specific functions.
In leukaemia, the process of creating new white blood cells becomes uncontrolled. Immature white blood cells (blasts) continue to multiply rapidly. As these leukaemia cells accumulate, they crowd out the healthy white cells, red cells, and platelets in the bone marrow. This imbalance prevents the bone marrow from making healthy blood cells, leading to symptoms such as fatigue, infection, and easy bruising.
Leukaemia is classified based on the type of white blood cell affected:
Acute Myeloid Leukaemia (AML):
AML originates from abnormal myeloid cells.
Acute Lymphoblastic Leukaemia (ALL):
ALL develops from abnormal lymphoblasts.
Chronic leukaemias are more commonly found in older adults.
If you are interested in more detailed information about acute lymphoblastic leukaemia (ALL), explore our dedicated sections on:
For a broader perspective on ALL that applies to people of all ages, refer to our general ALL section.
If you have symptoms that may be related to acute lymphoblastic leukaemia (ALL), it’s essential to consult your GP (General Practitioner). While symptoms of ALL can be caused by many different conditions, a medical evaluation is important to determine the cause and to arrange for any necessary tests.
During your appointment, your GP will:
The haematologist will:
Even if you have already had initial blood tests, further testing may be required to:
If you are diagnosed with ALL, further tests may be required to assess how your body is functioning. These may include:
While this may seem like a lot of tests, they provide critical information to guide your treatment. Accurate diagnosis and monitoring help doctors develop the most effective treatment plan tailored to your needs.
The primary treatment for acute lymphoblastic leukaemia (ALL) is chemotherapy. This involves the use of anti-cancer drugs to eliminate leukaemia cells, often in combination with steroids to enhance the effectiveness of the chemotherapy.
ALL treatment can be intensive at times and may cause side effects. Hospital staff are always available to support you during difficult moments. It’s important to communicate openly with your doctors and nurses about how you’re feeling. They can provide medications and support to help manage side effects and keep you strong throughout treatment.
ALL is typically treated in three phases:
Chemotherapy usually begins soon after diagnosis and is administered in a hospital setting to closely monitor your health. Patients aged 18 or younger will be treated at a Principal Treatment Centre (PTC) for teenagers and young adults (TYA). Patients aged 19 or older have the option of treatment at the PTC or a TYA-designated hospital closer to home.
The initial phase focuses on eliminating as many leukaemia cells as possible. Achieving remission means there is no detectable sign of leukaemia cells in your blood or bone marrow.
This phase usually takes about 5 weeks but may vary. During this time, you will stay in the hospital to closely monitor your progress.
Since traditional chemotherapy may not effectively reach the brain or spinal cord, intrathecal therapy is administered. Methotrexate is injected into the cerebrospinal fluid (CSF) to target hidden leukaemia cells in the CNS.
Most people do not experience significant side effects, but potential reactions include:
After achieving remission, further treatment is needed to eliminate any remaining leukaemia cells. This phase involves using various chemotherapy drugs to prevent drug resistance. Treatment lasts about 5 to 6 months and may involve outpatient visits or short hospital stays.
Maintenance therapy is aimed at preventing relapse by using low doses of chemotherapy over a longer period. Most of this treatment is conducted on an outpatient basis, allowing you to continue with daily activities. Maintenance therapy typically lasts just over 3 years for boys and just over 2 years for girls.
Regular check-ups, usually every week or two, are essential to monitor progress, adjust drug doses, and address any concerns.
Treatment can be challenging, and side effects may include:
Talking to friends, family, doctors, nurses, or support groups can make it easier to manage the emotional and physical challenges.